• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西肾结石评估与临床管理指南:巴西肾脏病学会

Brazilian Guidelines on evaluation and clinical management of Nephrolithiasis: Brazilian Society of Nephrology.

作者信息

Carvalho Mauricio de, Matos Ana Cristina Carvalho de, Santos Daniel Rinaldi Dos, Barreto Daniela Veit, Barreto Fellype Carvalho, Rodrigues Fernanda Guedes, Pietrobom Igor Gouveia, Luz Lucas Gobetti da, Constancio Natasha Silva, Gomes Samirah Abreu, Heilberg Ita Pfeferman

机构信息

Universidade Federal do Paraná, Hospital de Clínicas, Curitiba, PR, Brazil.

Pontifícia Universidade Católica do Paraná, Disciplina de Nefrologia, Curitiba, PR, Brazil.

出版信息

J Bras Nefrol. 2025 Apr-Jun;47(2):e20240189. doi: 10.1590/2175-8239-JBN-2024-0189en.

DOI:10.1590/2175-8239-JBN-2024-0189en
PMID:40080792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11913452/
Abstract

The prevalence of nephrolithiasis has been increasing in recent years, affecting appro-ximately 10% and 15% of the population. Kidney stone disease is associated with syste-mic comorbidities such as cardiovascular dis-ease, diabetes mellitus, and obesity. The first Nephrolithiasis Guideline by the Brazilian Society of Nephrology was published in 2002, and since then, the accumulation of new clinical studies and guidelines has justified a review of the subject. This updated document, prepared by the Nephrolithiasis Committee of the Brazilian Society of Nephrology, reflects the advances in the management of patients with kidney stones. The guideline aims to provide recommendations for the diagnosis, prevention, and treatment of nephrolithiasis, based on the best available evidence. Topics covered include clinical evaluation, laboratory and imaging tests, as well as dietary and pharmacological interventions, and follow-up strategies.

摘要

近年来,肾结石的患病率一直在上升,影响了约10%至15%的人口。肾结石疾病与心血管疾病、糖尿病和肥胖等全身性合并症相关。巴西肾脏病学会发布的首个肾结石指南于2002年发布,自那时起,新的临床研究和指南的积累使得对该主题进行重新审视成为必要。这份由巴西肾脏病学会肾结石委员会编写的更新文件反映了肾结石患者管理方面的进展。该指南旨在根据现有最佳证据,为肾结石的诊断、预防和治疗提供建议。涵盖的主题包括临床评估、实验室和影像学检查,以及饮食和药物干预措施,还有随访策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/501fc4d563d9/2175-8239-jbn-47-2-e20240189-gf10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/5caa4ba07e83/2175-8239-jbn-47-2-e20240189-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/9dcc70444f08/2175-8239-jbn-47-2-e20240189-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/fbc474d06add/2175-8239-jbn-47-2-e20240189-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/a400a4b2bb30/2175-8239-jbn-47-2-e20240189-gf04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/3f0a3e55668a/2175-8239-jbn-47-2-e20240189-gf05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/e0e2f2362f60/2175-8239-jbn-47-2-e20240189-gf06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/04aa80f1c431/2175-8239-jbn-47-2-e20240189-gf07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/0ca977debbfa/2175-8239-jbn-47-2-e20240189-gf08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/b5b0eefcfe29/2175-8239-jbn-47-2-e20240189-gf09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/501fc4d563d9/2175-8239-jbn-47-2-e20240189-gf10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/5caa4ba07e83/2175-8239-jbn-47-2-e20240189-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/9dcc70444f08/2175-8239-jbn-47-2-e20240189-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/fbc474d06add/2175-8239-jbn-47-2-e20240189-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/a400a4b2bb30/2175-8239-jbn-47-2-e20240189-gf04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/3f0a3e55668a/2175-8239-jbn-47-2-e20240189-gf05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/e0e2f2362f60/2175-8239-jbn-47-2-e20240189-gf06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/04aa80f1c431/2175-8239-jbn-47-2-e20240189-gf07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/0ca977debbfa/2175-8239-jbn-47-2-e20240189-gf08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/b5b0eefcfe29/2175-8239-jbn-47-2-e20240189-gf09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c1/11913452/501fc4d563d9/2175-8239-jbn-47-2-e20240189-gf10.jpg

相似文献

1
Brazilian Guidelines on evaluation and clinical management of Nephrolithiasis: Brazilian Society of Nephrology.巴西肾结石评估与临床管理指南:巴西肾脏病学会
J Bras Nefrol. 2025 Apr-Jun;47(2):e20240189. doi: 10.1590/2175-8239-JBN-2024-0189en.
2
Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management.临床综述。2012 年肾结石:发病机制、诊断与治疗。
J Clin Endocrinol Metab. 2012 Jun;97(6):1847-60. doi: 10.1210/jc.2011-3492. Epub 2012 Mar 30.
3
[Diagnosis and treatment of nephrolithiasis. What is established?].[肾结石的诊断与治疗。已确定了什么?]
Internist (Berl). 2015 Dec;56(12):1361-8. doi: 10.1007/s00108-015-3758-0.
4
Kidney Stone Pathophysiology, Evaluation and Management: Core Curriculum 2023.《肾结石病理生理学、评估和管理:2023 年核心课程》。
Am J Kidney Dis. 2023 Nov;82(5):617-634. doi: 10.1053/j.ajkd.2023.03.017. Epub 2023 Aug 9.
5
[Ultrasonography for diagnosis and management of nephrolithiasis: state of the art and new perspectives].[超声检查在肾结石诊断与治疗中的应用:现状与新视角]
G Ital Nefrol. 2020 Aug 3;37(Suppl 75):2020-S75.
6
Update on nephrolithiasis management.肾结石治疗的最新进展。
Minerva Urol Nefrol. 2007 Sep;59(3):317-25.
7
I Brazilian guideline on hypertension in dialysis of the Brazilian Society of Nephrology.我是巴西肾脏病学会巴西透析高血压指南。 (此译文逻辑较怪,原英文表述不太完整准确,可能正确表述是:我是巴西肾脏病学会发布的巴西透析高血压指南 ) 按现有英文直接翻译就是这样,供你参考。
J Bras Nefrol. 2025 Jan-Mar;47(1):e20240033. doi: 10.1590/2175-8239-JBN-2024-0033en.
8
Radiation Exposure during the Evaluation and Management of Nephrolithiasis.肾结石评估与管理过程中的辐射暴露
J Urol. 2015 Oct;194(4):878-85. doi: 10.1016/j.juro.2015.04.118. Epub 2015 Jun 6.
9
Risk factors for subsequent stone events in pediatric nephrolithiasis: A multi-institutional analysis.小儿肾结石中后续结石事件的风险因素:多机构分析。
J Pediatr Urol. 2022 Feb;18(1):26.e1-26.e9. doi: 10.1016/j.jpurol.2021.11.012. Epub 2021 Nov 25.
10
Current Trends, Evaluation, and Management of Pediatric Nephrolithiasis.儿童肾结石的现状、评估和治疗。
JAMA Pediatr. 2015 Oct;169(10):964-70. doi: 10.1001/jamapediatrics.2015.1419.

本文引用的文献

1
24-Hour Urinary Chemistries and Kidney Stone Risk.24 小时尿液化学成分分析与肾结石风险。
Am J Kidney Dis. 2024 Aug;84(2):164-169. doi: 10.1053/j.ajkd.2024.02.010. Epub 2024 Apr 5.
2
Sodium-glucose cotranspor ter 2 (SGLT2) inhibitors in nephrolithiasis: should we "gliflozin" patients with kidney stone disease?钠-葡萄糖共转运蛋白 2(SGLT2)抑制剂在肾结石中的应用:我们是否应该给肾结石患者使用“格列净”?
J Bras Nefrol. 2024 Jul-Sep;46(3):e20230146. doi: 10.1590/2175-8239-JBN-2023-0146en.
3
Urological Guidelines for Kidney Stones: Overview and Comprehensive Update.
肾结石的泌尿外科指南:概述与全面更新
J Clin Med. 2024 Feb 16;13(4):1114. doi: 10.3390/jcm13041114.
4
What's new in the New International Alliance of Urolithiasis (IAU) guidelines.新的国际尿石症联盟(IAU)指南有哪些新内容?
Urolithiasis. 2023 Dec 20;52(1):14. doi: 10.1007/s00240-023-01513-8.
5
Thiazide Use for the Prevention of Recurrent Calcium Kidney Stones.噻嗪类药物用于预防复发性钙肾结石。
Clin J Am Soc Nephrol. 2023 Dec 14;19(5):653-5. doi: 10.2215/CJN.0000000000000399.
6
2022 Recommendations of the AFU Lithiasis Committee: Epidemiology, stone analysis and composition.2022 年 AFU 结石委员会推荐意见:流行病学、结石分析和成分。
Prog Urol. 2023 Nov;33(14):737-765. doi: 10.1016/j.purol.2023.08.013.
7
Twenty-four-hour urine oxalate and risk of chronic kidney disease.24 小时尿草酸盐与慢性肾脏病风险。
Nephrol Dial Transplant. 2024 Apr 26;39(5):788-794. doi: 10.1093/ndt/gfad221.
8
Kidney stones and thiazide diuretics: revisiting old assumptions in light of the NOSTONE trial.肾结石与噻嗪类利尿剂:基于NOSTONE试验重新审视旧有假设。
Clin Kidney J. 2023 May 27;16(9):1372-1374. doi: 10.1093/ckj/sfad126. eCollection 2023 Sep.
9
The Optimal Length of Pharmacological Prophylaxis in Calcium Kidney Stone Formers.钙肾结石患者药物预防的最佳时长
Kidney360. 2023 Sep 1;4(9):e1318-e1321. doi: 10.34067/KID.0000000000000203.
10
Big data-based parathyroid hormone (PTH) values emphasize need for age correction.基于大数据的甲状旁腺激素 (PTH) 值强调需要进行年龄校正。
J Endocrinol Invest. 2023 Dec;46(12):2525-2533. doi: 10.1007/s40618-023-02107-2. Epub 2023 Jun 8.